2012
DOI: 10.1016/j.vph.2011.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
15
1

Year Published

2012
2012
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(19 citation statements)
references
References 31 publications
3
15
1
Order By: Relevance
“…AMPK, as an energy sensor, is ubiquitously expressed in vascular cells, and exerts anti-atherosclerotic effects associated to suppression of inflammatory responses [44-46]. The beneficial effects of adiponectin on cardiovascular diseases are expected to be partially mediated by activation of AMPK signalling pathway [47].…”
Section: Discussionmentioning
confidence: 99%
“…AMPK, as an energy sensor, is ubiquitously expressed in vascular cells, and exerts anti-atherosclerotic effects associated to suppression of inflammatory responses [44-46]. The beneficial effects of adiponectin on cardiovascular diseases are expected to be partially mediated by activation of AMPK signalling pathway [47].…”
Section: Discussionmentioning
confidence: 99%
“…Inhibition of VDCC with nifedipine and other VDCC blockers significantly attenuates smooth muscle cell proliferation cultured in media containing growth factors and serum (30,49,55), which would indicate that Ca 2ϩ influx through L-type and T-type VDCC is required for smooth muscle cell proliferation. Silenced expression of T-type VDCC in human PASMC was also shown to significantly attenuate proliferation (44), providing further evidence that T-type channels are essential in controlling prolif- eration.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, no change in the potent relaxation activity of nifedipine, another type of VDCC blocker, between young and aged SHR (and WKY) was found irrespective to their different VDCC expressions (Figures 5 and 6). This might be explained by alternative roles of nifedipine in vasorelaxation signaling pathways by activating AMP-activated protein kinase [29] and endothelial NO synthase [30]. However, further study on the relationship between activation of relaxation-signaling pathways by VDCC blockers and aging is needed.…”
Section: Discussionmentioning
confidence: 99%